Cargando…

Tautomerism in structure-based 3D pharmacophore modeling

Detalles Bibliográficos
Autores principales:	Seidel, Thomas, Wolber, G, Langer, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236210/ http://dx.doi.org/10.1186/1752-153X-2-S1-P11

Ejemplares similares

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
por: Wolber, Gerhard
Publicado: (2008)

3D pharmacophore alignments: does improved geometric accuracy affect virtual screening performance?
por: Wolber, Gerhard, et al.
Publicado: (2010)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Using structure- and Ligand-based pharmacophores as filters to discriminate Human Aryl Sulfotransferase 1A1 (SUL1A1) binders into substrates and inhibitors
por: Soliman, Salwa M, et al.
Publicado: (2014)

Ligand-side tautomer enumeration and scoring for structure-based drug-design
por: Seidel, Thomas, et al.
Publicado: (2010)

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction
por: Rakers, Christin, et al.
Publicado: (2014)

Hydrogen placement in protein-ligand complexes under consideration of tautomerism
por: Bietz, S, et al.
Publicado: (2011)

Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections
por: Del Rio, A, et al.
Publicado: (2011)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Brute-force pharmacophore assessment and scoring with Open3DQSAR
por: Tosco, P, et al.
Publicado: (2011)

Automatic pharmacophore model generation using weighted substructure assignments
por: Jahn, Andreas, et al.
Publicado: (2010)

Pharmacophore annotation using extended Hückel theory
por: Labute, Paul, et al.
Publicado: (2014)

pharmACOphore: multiple flexible ligand alignment based on ant colony optimization
por: Hessler, Gerhard, et al.
Publicado: (2010)

A ligand-based 3D pharmacophore model for the μ opioid receptor: application to the morphinan class of opioids
por: Asim, Muhammad Faheem, et al.
Publicado: (2010)

Discovery of novel α-amylase inhibitors using structure-based drug design
por: Al-Asri, Jamil, et al.
Publicado: (2014)

Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations
por: Wieder, Marcus, et al.
Publicado: (2016)

Cavka – a new automatic pharmacophore elucidation method in progress
por: Koelling, F, et al.
Publicado: (2011)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
por: Kutlushina, Alina, et al.
Publicado: (2018)

Hierarchical Graph Representation of Pharmacophore Models
por: Arthur, Garon, et al.
Publicado: (2020)

In silico identification of novel PKC βII inhibitors: ligand and receptor based pharmacophore modeling, virtual screening, and molecular dynamics study
por: Grewal, Baljinder K, et al.
Publicado: (2012)

Greedy 3-Point Search (G3PS)—A Novel Algorithm for Pharmacophore Alignment
por: Permann, Christian, et al.
Publicado: (2021)

QPHAR: quantitative pharmacophore activity relationship: method and validation
por: Kohlbacher, Stefan M., et al.
Publicado: (2021)

KRIPO – a structure-based pharmacophores approach explains polypharmacological effects
por: Ritschel, Tina, et al.
Publicado: (2014)

Applications of the Pharmacophore Concept in Natural Product inspired Drug Design
por: Seidel, Thomas, et al.
Publicado: (2020)

Discovery of novel TLR modulators by Molecular Modeling and Virtual Screening
por: Murgueitio, Manuela S, et al.
Publicado: (2012)

Virtual screening using structure-based consensus pharmacophore models and ensemble docking based on MD-generated conformations
por: Koch, Oliver, et al.
Publicado: (2011)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Chemical Structure-Biological Activity Models for Pharmacophores’ 3D-Interactions
por: Putz, Mihai V., et al.
Publicado: (2016)

Mind the Gap—Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence
por: Noonan, Theresa, et al.
Publicado: (2022)

Apo2ph4: A Versatile Workflow for the Generation of Receptor-based Pharmacophore Models for Virtual Screening
por: Heider, Jörg, et al.
Publicado: (2022)

Tautomeric Forms of Metarhodopsin
por: Matthews, Rowena G., et al.
Publicado: (1963)

How the methodology of 3D structure preparation influences the quality of QSPR models?
por: Geidl, Stanislav, et al.
Publicado: (2012)

Dualsteric modulators of the M2 muscarinic acetylcholine receptor
por: Bermudez, Marcel, et al.
Publicado: (2014)

MOGADOC: a database with 3D-structures
por: Vogt, Jürgen, et al.
Publicado: (2014)

Tautomerism in large databases
por: Sitzmann, Markus, et al.
Publicado: (2010)

Tautomerism of Guanine Analogues
por: Štoček, Jakub Radek, et al.
Publicado: (2020)

Molecular Docking and 3D-Pharmacophore Modeling to Study the Interactions of Chalcone Derivatives with Estrogen Receptor Alpha
por: Muchtaridi, Muchtaridi, et al.
Publicado: (2017)

Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation
por: Schuster, Daniela, et al.
Publicado: (2011)

Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation
por: Kohlbacher, Stefan Michael, et al.
Publicado: (2022)

Symmetry-breaking dynamics in a tautomeric 3D covalent organic framework
por: Xu, Yangyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_509k2ai3bic4bphtld6blm5cd4